About EKF
Point-of-care
Back
Point-of-care
EKF develops point-of-care in-vitro diagnostic devices and tests, providing quick, accurate results for healthcare professionals to make rapid decisions at or near the patient’s location.
Learn more
Diabetes Care
Precise analyzers for glucose, HbA1C, lactate, and B-HB measurement.
Biosen C-Line
Quo-Test®
STAT-Site® WB
Quo-Lab®
Hematology
Hemoglobin analyzers for improved diagnostics, blood donation and anemia tests.
DiaSpect Tm
Hemo Control
HemataStat II™
Connectivity
Connecting POC devices to IT systems, for real-time data and device management.
EKF Link
Women’s Health
Rapid analyzers for pregnancy, childbirth, and mother’s milk lipid content.
Creamatocrit Plus™
Pregnancy Tests
Sports
Lactate and glucose analyzers for optimized sports training and performance.
Lactate Scout Sport
Biosen C-Line
Veterinary Care
Vet analyzers for lactate, hemoglobin, and hematocrit to improve clinical decisions.
Lactate Scout Vet
Hemo Vet
Life Sciences
Back
Life Sciences
EKF supplies high-quality reagents, enzymes, and components for research, biotech, and pharma, supporting the delivery of industrial and life sciences applications.
Learn more
Precision Fermentation
Facilities and technologies that scale the fermentation of biomaterials in healthcare.
Custom Bioprocessing
Downstream processing that supports dynamic healthcare and biotechnology needs.
Diagnostic Enzymes
Diagnostic enzymes for clinical, biotechnology, and industrial applications.
Arylacylamidase (A-010)
Beta-Hydroxybutyrate Dehydrogenase (H-010)
Salicylate Hydroxylase (S-010)
OEM Support & Services
Production of premium products to meet clients precise requirements.
Central Laboratory
Back
Central Laboratory
EKF develops devices, tests, and media for high-throughput, accurate analysis in central labs, ensuring reliable results and precise diagnostics for healthcare professionals.
Learn more
Reagents
B-HB reagents that detect ketones and monitor diabetic ketoacidosis (DKA).
Beta-Hydroxybutyrate LiquiColor®
Immunoassay
Rapid tests for C-reactive protein (CRP), Rheumatoid Factor, and Syphilis.
RaPET®
Infectious Diseases
Detect Group A Streptococcal Antigen quickly, with enhanced sensitivity for early diagnosis.
QuStick™
Occult Blood
Test kits for Occult Blood, aiding early colorectal cancer detection affordably.
Hema-Screen®
Transport Media
Preserve and stabilize DNA/RNA for safe transport and accurate molecular testing.
PrimeStore®
Lab Analyzers
Using state-of-the-art tech for accurate and efficient testing with dedicated lab analyzers.
Uri-Trak® 120M
Clinical Chemistry
Liquid-stable reagents, calibrators and controls for major brand analyzers.
News & Events
Careers
Support Centre
Investors
Contact

Directors and Advisors

EKF specialises in diagnostics and biotechnology patient-centric solutions

Pebble

Executive Directors

Julian Baines, Executive Chairman

Julian rejoined the executive team at EKF Diagnostics Holdings plc ("EKF") as Executive Chairman on a short term basis as announced in early February 2023. Julian is also currently Non-Executive Chairman of Verici Dx plc. Julian has significant experience in the life science industry.

Stephen Young, Chief Financial Officer

Stephen is an experienced Finance Director and CFO and joins EKF Diagnostics from Trellus Health plc ("Trellus") where he has served as Interim Chief Financial Officer, in a non-board capacity, since August 2022.

Non-Executive Directors

Christopher Mills, Non-Executive Director

Christopher founded Harwood Capital Management in 2011, a successor to its former parent company J.O. Hambro Capital Management, which he co-founded in 1993.

Christian Rigg, Senior Independent Non-Executive Director

Chris Rigg has significant executive experience at both public and private companies. He is currently the Chief Executive Officer of Mandata Holdings Limited and a Non-Executive Director of the main market listed Sportech plc.

Jenny Winter, Non-Executive Director

Jenny has over 20 years’ experience across a broad variety of healthcare organisations ranging from small not-for-profit companies to large corporates. Jenny is currently Chief Executive Officer of AIM listed Animalcare Group plc (AIM: ANCR) where she is successfully executing on the business’s long-term growth strategy, as reflected in the recently announced strong full year trading performance against a backdrop of very challenging market conditions.

Advisors

Nominated Advisor and Broker:

Singer Capital Markets, 1 Bartholomew Lane, London, EC2N 2AX

Auditors:

PricewaterhouseCoopers LLP, One Kingsway, Cardiff, CF10 3PW

Bankers:

HSBC, 56 Queen Street, Cardiff, CF10 2PX

Financial PR & Investor Relations:

Walbrook PR Limited, 75 King William Street, London, EC4N 7BE, +44 (0)20 7933 8780, ekf@walbrookpr.com

Registrars:

Link Group, Central Square, 29 Wellington Street ,Leeds, LS1 4DL

If you have a query regarding your shareholding please call the Link shareholder helpline on +44 (0)371 664 0300 (UK calls are charged at the standard geographic rate and will vary by provider) or visit their website at www.linkgroup.eu or the Link Investor centre at https://investorcentre.linkgroup.co.uk/Login/Login

Company Secretary:

ONE Advisory Limited, 201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT